Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3526 |
|
| Actual shortage: | 232 (7%) | |
| Anticipated shortage: | 3 (0%) | |
| Avoided shortage: | 11 (0%) | |
| Resolved: | 3280 (93%) | |
Discontinuation Reports |
366 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 342 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
32 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-HALOPERIDOL LIQ 2MG/ML | 2MG | SOLUTION | Actual shortage | 2017-08-13 | 2017-10-05 | 18957 |
| APO HALOPERIDOL TAB 0.5MG | .5MG | TABLET | Actual shortage | 2017-08-11 | 2017-10-05 | 18760 |
| APO HALOPERIDOL TAB 1MG | 1MG | TABLET | Actual shortage | 2017-08-11 | 2017-10-05 | 18763 |
| APO-HYDROCHLOROTHIAZIDE | 100MG | TABLET | Resolved | 2017-03-10 | 2019-11-26 | 330 |
| APO-HYDROCHLOROTHIAZIDE | 50MG | TABLET | Resolved | 2018-04-24 | 2018-07-03 | 47102 |
| APO-IBUPROFEN | 300MG | TABLET | Resolved | 2019-06-05 | 2021-01-11 | 85597 |
| APO-IBUPROFEN | 400MG | TABLET | Resolved | 2018-11-16 | 2018-12-08 | 67023 |
| APO-IBUPROFEN | 400MG | TABLET | Resolved | 2019-03-05 | 2021-01-11 | 77890 |
| APO-IBUPROFEN | 400MG | TABLET | Resolved | 2019-03-20 | 2020-04-01 | 79042 |
| APO-IBUPROFEN | 400MG | TABLET | Resolved | 2020-10-14 | 2021-01-11 | 126283 |
| APO-IBUPROFEN TAB 600MG | 600MG | TABLET | Resolved | 2018-03-13 | 2018-05-09 | 42694 |
| APO-IBUPROFEN TAB 600MG | 600MG | TABLET | Resolved | 2019-01-09 | 2021-01-04 | 71665 |
| APO-IBUPROFEN TAB 600MG | 600MG | TABLET | Resolved | 2021-04-16 | 2021-05-01 | 137575 |
| APO-INDOMETHACIN | 25MG | CAPSULE | Actual shortage | 2017-08-13 | 2017-10-05 | 18961 |
| APO-INDOMETHACIN | 50MG | CAPSULE | Actual shortage | 2017-08-13 | 2017-10-05 | 18964 |
| APO METHAZIDE 15 | 15MG 250MG | TABLET | Actual shortage | 2017-08-11 | 2017-10-05 | 18916 |
| APO METHAZIDE 25 | 25MG 250MG | TABLET | Actual shortage | 2017-08-13 | 2017-10-05 | 18936 |
| APO-METOPROLOL (TYPE L) | 50MG | TABLET | Resolved | 2020-10-28 | 2020-11-09 | 127363 |
| APO-METOPROLOL (TYPE L) | 50MG | TABLET | Resolved | 2021-01-22 | 2021-02-11 | 132358 |
| APO-METOPROLOL | 100MG | TABLET | Resolved | 2020-05-08 | 2020-07-20 | 114300 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MELPHALAN FOR INJECTION | 10ML 50MG | POWDER FOR SOLUTION KIT SOLUTION | Discontinued | 2022-03-23 | 2022-03-23 | 157136 |
| NAPROXEN SODIUM TABLETS | 220MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71228 |
| APO-PENTOXIFYLLINE SR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-23 | 2022-01-27 | 65438 |
| APO-TEMAZEPAM | 15MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65477 |
| APO-TEMAZEPAM | 30MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-07 | 65482 |
| TIGECYCLINE | 50MG | POWDER FOR SOLUTION | To be discontinued | 2019-06-21 | 2019-06-21 | 87218 |